Bioimaging Core Facility The Bioimaging Core Facility is specialized in light microscopy. ChemBioMS - Mass Spectrometry Core Facility The ChemBiosMS - Mass Spectrometry Core Facility is a platform ...

Researchers explored the effect of immune checkpoint inhibitors on psoas muscle density and skeletal muscle index in patients with melanoma.

MILFORD, Mass., March 11, 2026 /PRNewswire/ -- UMass Memorial Health – Milford Regional Medical Center and Shields Health announced a new joint venture partnership to provide advanced imaging services ...

Diagnosis of stomach cancer (also known as gastric cancer) is now occurring more often at earlier stages, likely related to advances in tests and imaging. Importantly, stomach cancer is also being ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.

One recent study linked a lower risk of Alzheimer's disease and cognitive decline to lifelong learning and intellectually stimulating experiences.

The Bon Secours Hospital in Co Limerick was officially opened on Monday. It is the first new acute hospital to open in Ireland in two decades. The €213 million project is one of the largest healthcare ...

For people antidepressants can’t help, ketamine changes the brain in ways we can now see In A Nutshell For the first time, researchers used a specialized brain scan to watch how ketamine alters a key ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Major depressive disorder (MDD) is a major global health problem and one of the leading causes of disability. About 30% of people diagnosed with ...

A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with treatment-resistant depression. Researchers tracked changes in a critical brain receptor ...